Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B-Authors’ Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Prevalence of Hepatitis B and Hepatitis C in Patients of Chronic Kidney Disease

International Journal of Research in Medical Sciences
2019English

Editorial: Effect of Hepatic Steatosis on Liver Stiffness in Patients With Chronic Hepatitis B-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Risk of Developing Hepatocellular Carcinoma in Untreated HBeAg-negative Chronic Hepatitis B Patients With High Viral Load and No Significant ALT Elevation. Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: The Association Between Chronic Viral Hepatitis and Metabolic Syndrome - Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: HBsAg Kinetics-Guided Interferon Therapy for Chronic Hepatitis D - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Hepatocellular Carcinoma Risk After Hepatitis B Surface Antigen Seroclearance - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Lipid-Lowering Effect of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B-More Evidence Is Needed. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients

Hepatitis Monthly
HepatologyInfectious Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy